a company which translates genome editing technology into a novel class of human therapeutics
Industry Biotechnology
A.I.dvisor indicates that over the last year, EDIT has been closely correlated with NTLA. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if EDIT jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To EDIT | 1D Price Change % | ||
---|---|---|---|---|
EDIT | 100% | -3.58% | ||
NTLA - EDIT | 66% Closely correlated | -3.24% | ||
CRSP - EDIT | 65% Loosely correlated | -1.85% | ||
BEAM - EDIT | 64% Loosely correlated | -1.57% | ||
PRME - EDIT | 52% Loosely correlated | -8.33% | ||
ALLO - EDIT | 51% Loosely correlated | -4.23% | ||
More |
Ticker / NAME | Correlation To EDIT | 1D Price Change % |
---|---|---|
EDIT | 100% | -3.58% |
EDIT (4 stocks) | 75% Closely correlated | -5.68% |
gene-based medicines (3 stocks) | 71% Closely correlated | -5.72% |
drugs (254 stocks) | 52% Loosely correlated | -1.72% |
biotechnology (238 stocks) | 34% Loosely correlated | -1.80% |
human (15 stocks) | 20% Poorly correlated | +1.86% |